# Actavis Inc. clinical trials: 95 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 95 trials with Actavis Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Actavis Inc.: 95 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/actavis-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 95
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 95, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 17, 2019 | NCT03954444 | A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" | Actavis Inc. | Phase 3 | Completed | Rosacea | 1,105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03954444) |
| March 19, 2019 | NCT03879837 | Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg | Actavis Inc. | Phase 3 | Completed | Asthma | 1,902 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03879837) |
| November 28, 2018 | NCT03756883 | Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma | Actavis Inc. | Phase 3 | Completed | Asthma | 999 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03756883) |
| April 17, 2018 | NCT03499873 | Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension | Actavis Inc. | Phase 3 | Completed | Cataract | 448 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03499873) |
| October 4, 2017 | NCT03301649 | Clinical Endpoint Study of Ivermectin 0.5% Lotion | Actavis Inc. | Phase 3 | Completed | Head Lice | 905 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03301649) |
| September 27, 2017 | NCT03294538 | Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis | Actavis Inc. | Phase 3 | Completed | Atrophic Vaginitis | 663 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03294538) |
| September 19, 2017 | NCT03287791 | A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea | Actavis Inc. | Phase 3 | Completed | Rosacea | 924 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03287791) |
| June 27, 2017 | NCT03200912 | An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis | Actavis Inc. | Phase 3 | Completed | ACTINIC KERATOSIS | 507 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03200912) |
| July 21, 2016 | NCT02840461 | Clinical Endpoint Study of Ivermectin 1% Cream | Actavis Inc. | Phase 3 | Completed | Moderate to Severe Papulopustular Rosacea | 630 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02840461) |
| June 6, 2016 | NCT02791308 | Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis | Actavis Inc. | Phase 3 | Completed | Atopic Dermatitis | 587 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02791308) |
| January 13, 2016 | NCT02654769 | A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis | Actavis Inc. | Phase 3 | Completed | Actinic Keratosis | 441 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02654769) |
| January 8, 2016 | NCT02651220 | Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris | Actavis Inc. | Phase 3 | Completed | Acne | 1,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02651220) |
| November 30, 2015 | NCT02616614 | Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris | Actavis Inc. | Phase 3 | Completed | Acne Vulgaris | 862 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02616614) |
| November 30, 2015 | NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | Actavis Inc. | Phase 3 | Completed | Actinic Keratosis | 422 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02616601) |
| July 30, 2015 | NCT02512042 | Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the... | Actavis Inc. | Phase 3 | Completed | Glaucoma | 973 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02512042) |
| July 15, 2015 | NCT02498418 | Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea | Actavis Inc. | Phase 3 | Completed | Diarrhea | 739 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02498418) |
| July 14, 2015 | NCT02496715 | Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics | Actavis Inc. | Phase 3 | Withdrawn | Asthma | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02496715) |
| July 13, 2015 | NCT02495857 | A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee | Actavis Inc. | Not applicable | Completed | Osteoarthritis | 599 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02495857) |
| July 13, 2015 | NCT02495168 | Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic... | Actavis Inc. | Phase 3 | Completed | Asthma | 1,714 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02495168) |
| December 24, 2014 | NCT02324270 | Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain | Actavis Inc. | Phase 3 | Completed | Ankle Sprain | 658 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02324270) |
| November 13, 2014 | NCT02289352 | Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema... | Actavis Inc. | Phase 3 | Completed | Rosacea | 462 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02289352) |
| October 17, 2014 | NCT02267746 | A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris | Actavis Inc. | Phase 3 | Completed | Acne Vulgaris | 893 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02267746) |
| August 7, 2014 | NCT02210689 | A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse®... | Actavis Inc. | Phase 3 | Completed | BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and... | 604 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02210689) |
| April 23, 2014 | NCT02120924 | A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea | Actavis Inc. | Phase 3 | Completed | Rosacea | 1,009 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02120924) |
| April 23, 2014 | NCT02120898 | A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses | Actavis Inc. | Phase 3 | Completed | Actinic Keratosis | 467 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02120898) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 66 |
| Phase 3 | 27 |
| Phase 4 | 1 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 93 |
| Withdrawn | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Keratosis, Actinic | 6 |
| Asthma | 4 |
| Rosacea | 4 |
| Acne Vulgaris | 3 |
| Lecithin Cholesterol Acyltransferase Deficiency | 2 |
| Atrophic Vaginitis | 1 |
| Glaucoma | 1 |
| Diarrhea | 1 |
| Osteoarthritis | 1 |
| Rhinitis, Allergic, Seasonal | 1 |
| Vaginosis, Bacterial | 1 |
| Lymphoma, Follicular | 1 |
| Dermatitis, Atopic | 1 |
| Cataract | 1 |
| Ankle Injuries | 1 |
| Fasting | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical research institutes in the United States](https://specstream.ai/data/businesses/medical-research-institutes/united-states)
- [Aircraft service companies in the United States](https://specstream.ai/data/businesses/aircraft-service-companies/united-states)
- [Handyman services in the United States](https://specstream.ai/data/businesses/handyman-services/united-states)
- [Steel fabricators in the United States](https://specstream.ai/data/businesses/steel-fabricators/united-states)
- [Divorce and family law firms in the United States](https://specstream.ai/data/businesses/divorce-and-family-law-firms/united-states)
- [Pharmaceutical products wholesalers in the United States](https://specstream.ai/data/businesses/pharmaceutical-products-wholesalers/united-states)
